Contineum Therapeutics (CTNM) News Today → Amazon's betting big on this unknown AI company (From Manward Press) (Ad) Free CTNM Stock Alerts $15.41 -0.05 (-0.32%) (As of 03:46 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 11, 2024 | investing.comContineum Therapeutics Inc (CTNM)May 8, 2024 | americanbankingnews.comContineum Therapeutics, Inc.'s (NASDAQ:CTNM) Quiet Period Will Expire on May 15thMay 2, 2024 | finance.yahoo.comContineum Therapeutics Announces Pricing of Initial Public OfferingApril 30, 2024 | marketbeat.comContineum Therapeutics (NASDAQ:CTNM) Now Covered by Analysts at Royal Bank of CanadaRoyal Bank of Canada started coverage on Contineum Therapeutics in a research report on Tuesday. They set an "outperform" rating and a $30.00 price target for the company. Get Contineum Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CTNM and its competitors with MarketBeat's FREE daily newsletter. Email Address Amazon's betting big on this unknown AI company (Ad)Amazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company. Discover why this company CTNM Media Mentions By Week CTNM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTNM News Sentiment▼0.530.55▲Average Medical News Sentiment CTNM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTNM Articles This Week▼26▲CTNM Articles Average Week Get Contineum Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CTNM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VNDA News Today NKTR News Today NATR News Today CRMD News Today INZY News Today MRSN News Today AQST News Today FBLG News Today ORGO News Today VSTM News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTNM) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBill Clinton Backing Biden Replacement???The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Contineum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
